Vesigenurtucel-L

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameVesigenurtucel-L
Drug Alias Namevesigenurtacel-LHS-4109IE620X9FYUMUC3gp96IgHLAA1
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCytotoxic T lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHeat Biologics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHeat Biologics
Active IndicationsN/A
Inactive IndicationsUrinary Bladder Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A